CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical research to translate promising therapeutic concepts into meaningful patient impact.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CLIN2 Awards: Funding Opportunity for Clinical Trials supports organizations conducting stem cell-based and genetic therapy trials to advance treatments for serious unmet medical needs.